Possible Mechanisms of Tau Spread and Toxicity in Alzheimer's Disease

Huiqin Zhang1, Yu Cao1, Lina Ma1

  • 1Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Insights

Pathological tau protein detaches from microtubules in tauopathies, leading to misfolding and Alzheimer's disease (AD) progression. This review explores how tau pathology spreads between brain cells in a prion-like manner.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Tau protein stabilizes microtubules (MTs) essential for neuronal function.
  • In tauopathies, including Alzheimer's disease (AD), tau detaches from MTs, misfolds, and drives pathology.
  • Evidence suggests tauopathies spread through neuroanatomically connected regions in a prion-like fashion.

Purpose of the Study:

  • To review current evidence on the nature of tau species responsible for pathology propagation.
  • To elucidate the mechanisms underlying tau pathology spread between cells and brain regions.

Main Methods:

  • Literature review of studies on tau protein, tauopathies, and neurodegenerative disease mechanisms.
  • Analysis of research on tau secretion, cellular uptake, and intercellular transfer.
  • Examination of "prion-like" propagation models in the context of tauopathies.

Main Results:

  • Detached tau proteins are implicated in initiating and spreading pathological changes.
  • Tau pathology propagation involves complex steps: detachment, misfolding, secretion, cellular uptake, and seeding.
  • The precise mechanisms of tau pathology propagation remain an active area of research.

Conclusions:

  • Understanding tau propagation is crucial for developing therapeutic strategies against tauopathies like AD.
  • Further research is needed to fully delineate the molecular mechanisms of tau spread.
  • Targeting tau transmission pathways may offer novel treatment avenues for neurodegenerative diseases.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
871
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
412
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.7K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.0K